However, the unresolved question of who would pay for claims for damages in the event of adverse effects from the inoculations has delayed the delivery.
New Zealand started its official rollout of Pfizer-BioNTech’s COVID-19 vaccine on Saturday, while Australia finalised plans to begin inoculations on Monday, a new phase in tackling the virus that both countries have kept largely contained.
New Zealand expects its nationwide rollout covering the country’s population of 5 million will take a full year, while Australia aims to inoculate its 25 million citizens by October.
Blinken said the United States would pay up its more than $200 million in obligations to the UN body by the end of the month and make a "significant" contribution to Covax.
The interim distribution list issued on February 3 broke down the programme's initial 337.2 million doses -- of which all barring 1.2 million Pfizer-BioNTech doses, are from AstraZeneca. Both WHO-approved vaccines require two injected doses.
South Korea’s intelligence agency said it had foiled North Korean attempts to hack into South Korean companies developing coronavirus vaccines.
North Korea is often accused of turning to an army of hackers to fill cash-strapped government coffers amid international sanctions that ban most international trade with the country.
Syrian health officials have said the country is engaged with Russia and China over vaccines but authorities have not yet announced any bilateral deals.
The country has signed up for COVAX, a global scheme backed by the World Health Organization to provide vaccines to poorer countries.
The distribution list includes doses of the AstraZeneca-Oxford vaccine, licensed to the Serum Institute of India, Pfizer-BioNTech vaccine and AstraZeneca-Oxford vaccine.
The distribution aims to cover an average of 3.3% of total population of 145 countries by mid-2021.
The foreign ministry said last month that three Chinese vaccine makers, Sinopharm, Sinovac and CanSino, had formally applied for inclusion in the Covax stockpile.
The Korea Disease Control and Prevention Agency reported 467 new cases by Tuesday, as numbers rebounded above 400 in four days, boosted by continuing cluster infections.
"Good news on COVID vaccine front. Received a letter from COVAX of [an] indicative supply of up to 17 million doses of AstraZeneca in 1st half 2021," says the Minister.
"We signed with COVAX nearly eight months back to ensure availability," he added.
The WHO signed an advance purchase agreement with the American pharmaceutical, where it will receive at least 40 million doses of the drug.
It also anticipates another 50 million doses from UK-based pharmaceutical Oxford-Astrazeneca. As per the existing agreement with the company, the shipment will be made in first quarter of the year.